My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 152

    1.

    Natural history of beta-cell function in type 1 diabetes.

    Sherry NA, Tsai EB, Herold KC.

    Diabetes. 2005 Dec;54 Suppl 2:S32-9. Review.PMID: 16306337 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prospective study of predictors of beta-cell survival in type I diabetes.

    Schiffrin A, Suissa S, Poussier P, Guttmann R, Weitzner G.

    Diabetes. 1988 Jul;37(7):920-5.PMID: 3290010 [PubMed - indexed for MEDLINE]Related articles

    3.

    Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.

    Fernandez Castañer M, Montaña E, Camps I, Biarnes J, Merino JF, Escriba JM, Nacher V, Rosel P, Soler J.

    Diabetes Metab. 1996 Oct;22(5):349-55.PMID: 8896997 [PubMed - indexed for MEDLINE]Related articles

    4.

    The rise and fall of insulin secretion in type 1 diabetes mellitus.

    Tsai EB, Sherry NA, Palmer JP, Herold KC.

    Diabetologia. 2006 Feb;49(2):261-70. Epub 2006 Jan 11. Review.PMID: 16404554 [PubMed - indexed for MEDLINE]Related articles

    5.

    C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

    Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW.

    Diabetes. 2004 Jan;53(1):250-64. Erratum in: Diabetes. 2004 Jul;53(7):1934. PMID: 14693724 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pathophysiology of insulin secretion.

    Scheen AJ.

    Ann Endocrinol (Paris). 2004 Feb;65(1):29-36. Review.PMID: 15122089 [PubMed - indexed for MEDLINE]Related articles

    7.

    C-peptide: an index of insulin secretion.

    Faber OK, Binder C.

    Diabetes Metab Rev. 1986;2(3-4):331-45. Review.PMID: 3527619 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin secretion in type 1 diabetes.

    Steele C, Hagopian WA, Gitelman S, Masharani U, Cavaghan M, Rother KI, Donaldson D, Harlan DM, Bluestone J, Herold KC.

    Diabetes. 2004 Feb;53(2):426-33.PMID: 14747294 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus.

    Klipper-Aurbach Y, Wasserman M, Braunspiegel-Weintrob N, Borstein D, Peleg S, Assa S, Karp M, Benjamini Y, Hochberg Y, Laron Z.

    Med Hypotheses. 1995 Nov;45(5):486-90.PMID: 8748093 [PubMed - indexed for MEDLINE]Related articles

    10.

    Markers of beta cell function in type 1 diabetes mellitus.

    Vendrame F, Zappaterreno A, Dotta F.

    Minerva Med. 2004 Apr;95(2):79-84. Review.PMID: 15272242 [PubMed - indexed for MEDLINE]Related articles

    11.

    Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment.

    Stenström G, Gottsäter A, Bakhtadze E, Berger B, Sundkvist G.

    Diabetes. 2005 Dec;54 Suppl 2:S68-72.PMID: 16306343 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.

    Fukui M, Nakamura N, Nakano K, Kondo M.

    Diabetes Care. 1999 Oct;22(10):1758-9. No abstract available. PMID: 10526760 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Islet-cell antibodies and beta-cell function in insulin-dependent diabetics.

    Madsbad S, Bottazzo GF, Cudworth AG, Dean B, Faber OK, Binder C.

    Diabetologia. 1980 Jan;18(1):45-7.PMID: 6988264 [PubMed - indexed for MEDLINE]Related articles

    14.

    [And what about diabetes?]

    Cerasi E.

    Bull Acad Natl Med. 2007 Apr-May;191(4-5):941-3; discussion 943. French. PMID: 18225448 [PubMed - indexed for MEDLINE]Related articles

    15.

    Protection of pancreatic beta-cells: is it feasible?

    Bonora E.

    Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. Review.PMID: 18096375 [PubMed - indexed for MEDLINE]Related articles

    16.

    Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.

    Ortqvist E, Björk E, Wallensteen M, Ludvigsson J, Aman J, Johansson C, Forsander G, Lindgren F, Berglund L, Bengtsson M, Berne C, Persson B, Karlsson FA.

    Diabetes Care. 2004 Sep;27(9):2191-7.PMID: 15333483 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Factors of importance for residual beta-cell function in type I diabetes mellitus. A review.

    Madsbad S.

    Acta Med Scand Suppl. 1983;671:61-7. No abstract available. PMID: 6349267 [PubMed - indexed for MEDLINE]Related articles

    18.

    Ingested IFN-alpha preserves residual beta cell function in type 1 diabetes.

    Brod SA, Atkinson M, Lavis VR, Brosnan PG, Hardin DS, Orlander PR, Nguyen M, Riley WJ.

    J Interferon Cytokine Res. 2001 Dec;21(12):1021-30.PMID: 11798459 [PubMed - indexed for MEDLINE]Related articles

    19.

    [The natural history of diabetes with respect to disorders of insulin function]

    Dorner M, Pinget M, Brogard JM, Sapin R, Paris-Bockel D, Levy P, Jung C.

    Journ Annu Diabetol Hotel Dieu. 1984:51-71. Review. French. No abstract available. PMID: 6399540 [PubMed - indexed for MEDLINE]Related articles

    20.

    [LADA--latent autoimmune diabetes in adults]

    Szelachowska M.

    Endokrynol Pol. 2007 May-Jun;58(3):246-51. Review. Polish. PMID: 17940991 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity